PT-141 (Bremelanotide) is a peptide studied for its effects on melanocortin receptors. It is known for its potential role in libido.
Note: Bremelanotide is an FDA-approved prescription treatment for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women in the United States.
